StockNews.com upgraded shares of Colgate-Palmolive (NYSE:CL – Free Report) from a hold rating to a buy rating in a research report released on Wednesday.
Several other brokerages have also recently weighed in on CL. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price target for the company from $105.00 to $101.00 in a research note on Monday, October 28th. UBS Group lifted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. TD Cowen reduced their target price on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Finally, JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $105.11.
Check Out Our Latest Stock Analysis on CL
Colgate-Palmolive Stock Up 0.1 %
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. Colgate-Palmolive’s dividend payout ratio is 57.31%.
Insider Activity at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.34% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Principal Financial Group Inc. lifted its holdings in shares of Colgate-Palmolive by 4.9% during the third quarter. Principal Financial Group Inc. now owns 997,147 shares of the company’s stock worth $103,514,000 after buying an additional 46,944 shares in the last quarter. DGS Capital Management LLC grew its position in shares of Colgate-Palmolive by 35.9% during the 3rd quarter. DGS Capital Management LLC now owns 8,625 shares of the company’s stock worth $895,000 after purchasing an additional 2,280 shares in the last quarter. Garde Capital Inc. increased its holdings in shares of Colgate-Palmolive by 19.5% during the third quarter. Garde Capital Inc. now owns 1,553 shares of the company’s stock worth $161,000 after purchasing an additional 253 shares during the period. Peapack Gladstone Financial Corp raised its position in shares of Colgate-Palmolive by 2.4% in the third quarter. Peapack Gladstone Financial Corp now owns 50,653 shares of the company’s stock valued at $5,258,000 after buying an additional 1,203 shares in the last quarter. Finally, Tidal Investments LLC boosted its stake in shares of Colgate-Palmolive by 351.0% in the third quarter. Tidal Investments LLC now owns 284,568 shares of the company’s stock valued at $29,541,000 after buying an additional 221,469 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Overbought Stocks Explained: Should You Trade Them?
- Work and Play: Investing in the Rise of Bleisure Travel
- Airline Stocks – Top Airline Stocks to Buy Now
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Election Stocks: How Elections Affect the Stock Market
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.